IMA
ImageneBio, Inc.
+0.32 (+6.49%)5.25USD12.1K成交股數59.6M市值–本益比(近四季)74.5股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 2 · 17K · 1 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 17K |
| 近 180 天 淨額 | −17K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 08-17 | Grant-Huerta Yanina | Chief Financial Officer | A 獲配股票 | 65.0K | – | – | 65.0K | SEC |
| 2026-08-14 | 08-17 | Yarema Kristin | Chief Executive Officer | A 獲配股票 | 255K | – | – | 494K | SEC |
| 2026-08-14 | 08-17 | Grant-Huerta Yanina | Chief Financial Officer | A 獲配股票 | 39.0K | – | – | 104K | SEC |
| 2026-07-25 | 07-28 | Yarema Kristin | Chief Executive Officer | J 其他 | 115K | – | – | 239K | SEC |
| 2026-07-25 | 07-28 | Yarema Kristin | Chief Executive Officer | M 選擇權執行 | 38.4K | – | – | 124K | SEC |
| 2026-07-17 | 07-20 | Lally Robert B | Principal Accounting Officer | S 公開市場賣出 | 1.5K | 5.34 | 8K | 55.6K | SEC |
| 2026-07-16 | 07-20 | Lally Robert B | Principal Accounting Officer | S 公開市場賣出 | 1.7K | 5.50 | 9K | 57.1K | SEC |
| 2026-03-16 | 03-18 | Yarema Kristin | Chief Executive Officer | A 獲配股票 | 85.4K | – | – | 85.4K | SEC |
| 2025-12-30 | 01-02 | Butler Erin | Principal Accounting Officer | A 獲配股票 | 22.5K | – | – | 25.6K | SEC |
| 2025-12-24 | 12-29 | SLATTERY JOSEPH P | Director | P 公開市場買進 | 16.0K | 5.99 | 96K | 16.0K | SEC |
| 2025-07-28 | 07-29 | Marango Jotin | Chief Financial Officer | F 繳稅扣股 | 4.6K | 17.16 | 79K | 11.1K | SEC |
| 2025-07-28 | 07-29 | Marango Jotin | Chief Financial Officer | A 獲配股票 | 15.8K | – | – | 15.8K | SEC |
| 2025-07-25 | 10-10 | Wang Stephen Hui | Director | A 獲配股票 | 188K | – | – | 188K | SEC |
| 2025-07-25 | 10-10 | Wang Stephen Hui | Director | A 獲配股票 | 12.5K | – | – | 12.5K | SEC |
| 2025-07-25 | 10-10 | Wang Stephen Hui | Director | A 獲配股票 | 50.1K | – | – | 50.1K | SEC |
| 2025-07-25 | 08-15 | Wang Jonathan Jian | Director | A 獲配股票 | 971K | – | – | 971K | SEC |
| 2025-07-25 | 08-15 | Wang Jonathan Jian | Director | A 獲配股票 | 144K | – | – | 144K | SEC |
| 2025-07-25 | 07-30 | ORBIMED ADVISORS LLC | Director | A 獲配股票 | 83.6K | 2.49 | 208K | 288K | SEC |
| 2025-07-25 | 07-30 | Bonita David P | Director | P 公開市場買進 | 83.6K | 29.90 | 2.5M | 288K | SEC |
| 2025-07-25 | 07-30 | Stampacchia Otello | Director | P 公開市場買進 | 268K | 29.90 | 8.0M | 455K | SEC |
| 2025-07-25 | 07-30 | Bonita David P | Director | M 選擇權執行 | 379 | – | – | 379 | SEC |
| 2025-07-25 | 07-30 | OrbiMed Capital GP VI LLC | Director | A 獲配股票 | 83.6K | 2.49 | 208K | 288K | SEC |
| 2025-07-25 | 07-30 | OrbiMed Genesis GP LLC | Director | A 獲配股票 | 83.6K | 2.49 | 208K | 288K | SEC |
| 2025-07-25 | 07-30 | Stampacchia Otello | Director | M 選擇權執行 | 379 | – | – | 379 | SEC |
| 2025-07-25 | 07-29 | Butler Erin | Principal Accounting Officer | A 獲配股票 | 3.1K | – | – | 3.1K | SEC |
| 2023-08-04 | 09-21 | OrbiMed Capital GP VI LLC | Director | A 獲配股票 | 153K | – | – | 5.6M | SEC |
| 2023-08-04 | 09-21 | ORBIMED ADVISORS LLC | Director | A 獲配股票 | 153K | – | – | 5.6M | SEC |
| 2023-08-04 | 09-21 | Bonita David P | Director | A 獲配股票 | 153K | – | – | 5.6M | SEC |
| 2023-08-04 | 09-21 | OrbiMed Genesis GP LLC | Director | A 獲配股票 | 153K | – | – | 5.6M | SEC |
| 2023-08-04 | 09-14 | Bonita David P | Director | A 獲配股票 | 153K | – | – | 2.3M | SEC |
| 2023-08-04 | 09-14 | ORBIMED ADVISORS LLC | Director | A 獲配股票 | 153K | – | – | 2.3M | SEC |
| 2023-08-04 | 09-14 | OrbiMed Genesis GP LLC | Director | A 獲配股票 | 153K | – | – | 2.3M | SEC |
| 2023-08-04 | 09-14 | OrbiMed Capital GP VI LLC | Director | A 獲配股票 | 153K | – | – | 2.3M | SEC |
| 2022-06-24 | 06-24 | OrbiMed Genesis GP LLC | Director | P 公開市場買進 | 96.0K | 5.37 | 516K | 2.1M | SEC |
| 2022-06-24 | 06-24 | OrbiMed Genesis GP LLC | Director | P 公開市場買進 | 66.0K | 4.37 | 288K | 2.0M | SEC |
| 2022-06-24 | 06-24 | OrbiMed Capital GP VI LLC | Director | P 公開市場買進 | 66.0K | 4.37 | 288K | 2.0M | SEC |
| 2022-06-24 | 06-24 | OrbiMed Capital GP VI LLC | Director | P 公開市場買進 | 96.0K | 5.37 | 516K | 2.1M | SEC |
| 2022-06-24 | 06-24 | ORBIMED ADVISORS LLC | Director | P 公開市場買進 | 96.0K | 5.37 | 516K | 2.1M | SEC |
| 2022-06-24 | 06-24 | ORBIMED ADVISORS LLC | Director | P 公開市場買進 | 66.0K | 4.37 | 288K | 2.0M | SEC |
| 2022-06-24 | 06-24 | Bonita David P | Director | P 公開市場買進 | 96.0K | 5.37 | 516K | 2.1M | SEC |
| 2022-06-24 | 06-24 | Bonita David P | Director | P 公開市場買進 | 66.0K | 4.37 | 288K | 2.0M | SEC |
| 2022-06-23 | 06-24 | OrbiMed Genesis GP LLC | Director | P 公開市場買進 | 23.4K | 3.71 | 87K | 1.9M | SEC |
| 2022-06-23 | 06-24 | OrbiMed Capital GP VI LLC | Director | P 公開市場買進 | 23.4K | 3.71 | 87K | 1.9M | SEC |
| 2022-06-23 | 06-24 | ORBIMED ADVISORS LLC | Director | P 公開市場買進 | 23.4K | 3.71 | 87K | 1.9M | SEC |
| 2022-06-23 | 06-24 | Bonita David P | Director | P 公開市場買進 | 23.4K | 3.71 | 87K | 1.9M | SEC |
| 2022-06-22 | 06-24 | Bonita David P | Director | P 公開市場買進 | 66.8K | 3.55 | 237K | 1.9M | SEC |
| 2022-06-22 | 06-24 | OrbiMed Genesis GP LLC | Director | P 公開市場買進 | 66.8K | 3.55 | 237K | 1.9M | SEC |
| 2022-06-22 | 06-24 | OrbiMed Capital GP VI LLC | Director | P 公開市場買進 | 66.8K | 3.55 | 237K | 1.9M | SEC |
| 2022-06-22 | 06-24 | ORBIMED ADVISORS LLC | Director | P 公開市場買進 | 66.8K | 3.55 | 237K | 1.9M | SEC |
| 2022-01-18 | 01-20 | Tessier Maude | Chief Business Officer | M 選擇權執行 | 8.3K | 4.51 | 37K | 101K | SEC |
| 2022-01-18 | 01-20 | Tessier Maude | Chief Business Officer | M 選擇權執行 | 24.6K | 4.15 | 102K | 92.3K | SEC |
| 2022-01-18 | 01-20 | Tessier Maude | Chief Business Officer | M 選擇權執行 | 38.9K | 2.94 | 114K | 67.7K | SEC |
| 2022-01-11 | 01-12 | Zhang Xiaoyan Michelle | Chief Scientific Officer | S 公開市場賣出 | 964 | 12.00 | 12K | 44.5K | SEC |
| 2022-01-11 | 01-12 | Zhang Xiaoyan Michelle | Chief Scientific Officer | M 選擇權執行 | 964 | 2.15 | 2K | 45.4K | SEC |
| 2022-01-10 | 01-12 | Zhang Xiaoyan Michelle | Chief Scientific Officer | S 公開市場賣出 | 36 | 12.00 | 432.00 | 44.5K | SEC |
| 2022-01-10 | 01-12 | Zhang Xiaoyan Michelle | Chief Scientific Officer | M 選擇權執行 | 36 | 2.15 | 77.40 | 44.5K | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Fund XI, L.P. | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | FORMELA JEAN FRANCOIS | Director | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Associates XI, LLC | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Associates XI, L.P. | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-14 | 12-14 | Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | S 公開市場賣出 | 6.0K | 14.00 | 83K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Fund XI, L.P. | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Associates XI, L.P. | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Associates XI, LLC | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-13 | 12-14 | FORMELA JEAN FRANCOIS | Director | S 公開市場賣出 | 8.3K | 14.64 | 122K | 1.2M | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Fund XI, L.P. | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | Zhang Xiaoyan Michelle | Chief Scientific Officer | S 公開市場賣出 | 1.0K | 14.76 | 15K | 44.5K | SEC |
| 2021-12-10 | 12-14 | Zhang Xiaoyan Michelle | Chief Scientific Officer | M 選擇權執行 | 1.0K | 2.15 | 2K | 45.5K | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Associates XI, L.P. | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Associates XI, LLC | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Associates Opportunity I, LLC | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Associates Opportunity I, L.P. | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-12-10 | 12-14 | FORMELA JEAN FRANCOIS | Director | S 公開市場賣出 | 12.0K | 15.03 | 180K | 1.3M | SEC |
| 2021-03-30 | 12-14 | Atlas Venture Opportunity Fund I, L.P. | TenPercentOwner | P 公開市場買進 | 125K | 16.00 | 2.0M | 875K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BVF INC/IL | 1.1M | 6.5M | 新進 | 新進 |
| Blue Owl Capital Holdings LP | 918K | 5.4M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 909K | 5.4M | 新進 | 新進 |
| Cable Car Capital, LP | 782K | 4.6M | 新進 | 新進 |
| Omega Fund Management, LLC | 455K | 2.7M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 334K | 2.0M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 321K | 1.9M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 282K | 1.7M | 新進 | 新進 |
| BML Capital Management, LLC | 201K | 1.2M | 新進 | 新進 |
| Monashee Investment Management LLC | 192K | 1.1M | 新進 | 新進 |
| BlackRock, Inc. | 135K | 797K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 86.9K | 513K | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 66.7K | 393K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 55.6K | 328K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 53.5K | 316K | 新進 | 新進 |
| NEA Management Company, LLC | 50.0K | 295K | 新進 | 新進 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 50.0K | 295K | 新進 | 新進 |
| HSBC HOLDINGS PLC | 34.2K | 208K | 新進 | 新進 |
| Sofinnova Investments, Inc. | 31.9K | 188K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 27.5K | 162K | 新進 | 新進 |
| Rangeley Capital, LLC | 20.1K | 119K | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 19.9K | 117K | 新進 | 新進 |
| Aldebaran Capital, LLC | 18.1K | 107K | 新進 | 新進 |
| Shay Capital LLC | 18.1K | 107K | 新進 | 新進 |
| MORGAN STANLEY | 16.7K | 98K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 35 -4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 35 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 6.2M · 54.9% |
| 合計季末市值 | 36.8M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 39.4K |
|---|---|
| 與上期比 | -20.1% |
| 佔流通股數 | 0.35% |
| 日均成交量 | 11.7K |
| 回補天數 | 3.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 39.4K | -20.1% | 0.35% | 11.7K | 3.4 |
| 2026-08-14 | 49.3K | -87.2% | 0.43% | 10.0K | 5.0 |
| 2026-07-31 | 385K | -2.3% | 3.39% | 13.0K | 29.6 |
| 2026-07-15 | 394K | -2.6% | 3.47% | 6.7K | 59.1 |
| 2026-06-30 | 404K | +2.1% | 3.56% | 12.8K | 31.5 |
| 2026-06-15 | 396K | -11.1% | 3.49% | 16.4K | 24.1 |
| 2026-05-29 | 445K | +0.1% | 3.92% | 15.7K | 28.4 |
| 2026-05-15 | 445K | -5.4% | 3.92% | 69.3K | 6.4 |
| 2026-04-30 | 470K | -19.9% | 4.14% | 61.7K | 7.6 |
| 2026-04-15 | 587K | +51.7% | 5.17% | 1.8M | 1.0 |
| 2026-03-31 | 387K | +2.4% | 3.41% | 42.8K | 9.1 |
| 2026-03-13 | 378K | -0.1% | 3.33% | 29.1K | 13.0 |
| 2026-02-27 | 379K | +2.4% | 3.33% | 37.9K | 10.0 |
| 2026-02-13 | 370K | -4.3% | 3.26% | 49.0K | 7.5 |
| 2026-01-30 | 386K | +0.5% | 3.40% | 40.9K | 9.4 |
| 2026-01-15 | 384K | -3.4% | 3.39% | 14.3K | 26.9 |
| 2025-12-31 | 398K | +3.2% | 3.50% | 80.8K | 4.9 |
| 2025-12-15 | 385K | +2.4% | 3.40% | 76.8K | 5.0 |
| 2025-11-28 | 376K | +0.2% | 3.32% | 49.5K | 7.6 |
| 2025-11-14 | 375K | +2.3% | 3.31% | 23.0K | 16.4 |
| 2025-10-31 | 367K | +249.9% | 3.23% | 96.8K | 3.8 |
| 2025-10-15 | 105K | +180.3% | 0.92% | 83.7K | 1.3 |
| 2025-09-30 | 37.4K | +150.5% | 0.33% | 80.0K | 1.0 |
| 2025-09-15 | 14.9K | +52.7% | 0.13% | 76.3K | 1.0 |
| 2025-08-29 | 9.8K | +22.8% | 0.09% | 9.2K | 1.1 |
| 2025-08-15 | 8.0K | -20.4% | 0.07% | 12.0K | 1.0 |